Skip to main content
Diseases

Lipodystrophy

lipodystrophy

Entity Type
Diseases
Relation Groups
2
Relation Preview
16

Basic Information

Grouped by core information, identifiers, and descriptions.

Quick relations do not expand inferred candidates by default. Load path-derived ingredients or herbs when needed.

Core Information

Disease Name
Lipodystrophy
Standard Disease Name
lipodystrophy
MeSH Tree
No data
ICD-10
E88.1

Identifiers

DO ID
No data
MeSH ID
D008060
OMIM ID
MTHU037286
UMLS ID
C0023787
HPO ID
No data

Description and Extensions

Description
NCI2016_02D:A congenital or acquired disorder characterized by abnormal loss or redistribution of the adipose tissue in the body.|MSH2017_2016_08_12:A collection of heterogenous conditions resulting from defective LIPID METABOLISM and characterized by ADIPOSE TISSUE atrophy. Often there is redistribution of body fat resulting in peripheral fat wasting and central adiposity. They include generalized, localized, congenital, and acquired lipodystrophy.|HPO2016_07_04:Degenerative changes of the fat tissue. [HPO:curators]|CSP2006:collection of rare conditions resulting from defective fat metabolism and characterized by atrophy of the subcutaneous fat; includes total, congenital or acquired, partial, abdominal infantile, and localized lipodystrophy.
Related

Direct relations and traceable candidates grouped by relation type.

Related Targets

target disease8 Targets
06
PCK1
phosphoenolpyruvate carboxykinase 1
phosphoenolpyruvate carboxykinase 1
07
PIK3R1
phosphoinositide-3-kinase regulatory subunit 1
phosphoinositide-3-kinase regulatory subunit 1